GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » Volatility

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Volatility : 41.20% (As of May. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-05-29), Ningbo Menovo Pharmaceutical Co's Volatility is 41.20%.


Competitive Comparison of Ningbo Menovo Pharmaceutical Co's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ningbo Menovo Pharmaceutical Co's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's Volatility distribution charts can be found below:

* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's Volatility falls into.



Ningbo Menovo Pharmaceutical Co  (SHSE:603538) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ningbo Menovo Pharmaceutical Co  (SHSE:603538) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Ningbo Menovo Pharmaceutical Co Volatility Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Ningbo Menovo Pharmaceutical Co (SHSE:603538) Business Description

Traded in Other Exchanges
N/A
Address
No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Executives
Xu Jian senior management
Cao Qian Director
Yao Fang Director
Ying Gao Feng Director
Sun Yan Director
Shi Jian Xiang Director
Wu Feng Yun Director
Tu Ying Director
Yao Cheng Zhi Director
Zheng Hui Lin Supervisors
Jiao Hua senior management

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Headlines

No Headlines